NCT00712868

CompletedPhase 4

Acceptability of Lactacyd Femina

Sanofi Source

Compare

Other study identifiers

Sponsor study identifier

LACAC_L_03447

Study Type

interventional

Actual enrollment (reported)

559

Locations

1 country

Sites

1

Timeline

Study Start

June 2008

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

August 2008

Actual (reported)

Study Completion

August 2008

Actual (reported)

Brief Summary

To demonstrate the safety and acceptability of the gynaecological formulation.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 559 participants
Study completion date: August 2008
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Some registry-reported names shown below are not yet linked in this graph.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
June 2008
Date type not reported
This date has not been verified as actual or estimated.
First Submitted
July 7, 2008
Actual (reported)
First Posted
July 10, 2008
Actual (reported)
Primary Completion
August 2008
Actual (reported)
Study Completion
August 2008
Actual (reported)

Last Updated: July 20, 2009
Status Verified: July 2009
Last Update Submitted: July 17, 2009

Conditions

Hygiene

Outcome Measures

Primary Outcomes (1)

Clinical and local tolerability
After 21 days

Study Arms (1)

1

EXPERIMENTAL

Lactic Acid once a day during 21 days

Drug: Lactic acid

Interventions

Lactic acidDrug

Once a day

1

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years - 60 Years

Sexfemale

Healthy VolunteersYes

Age GroupsAdult (18-64)

You may qualify if:

Integral skin in the tested region

You may not qualify if:

Sponsors & Collaborators

Sanofi
Industrylead

Study Sites (1)

Sanofi-Aventis Administrative Office

Col. Coyoacan, Mexico

MeSH Terms

Interventions

Lactic Acid

Intervention Hierarchy (Ancestors)

LactatesHydroxy AcidsCarboxylic AcidsOrganic Chemicals

Study Officials

Judith Diaz, Md
Sanofi
STUDY DIRECTOR

Enrollment

559 participants (actual enrollment reported by the registry).

Study Design

Study Type: interventional
Phase: phase 4
Allocation: NA
Masking: NONE
Purpose: TREATMENT
Intervention Model: SINGLE GROUP
Sponsor Type: INDUSTRY

Study Record Dates

First Submitted

July 7, 2008

First Posted

July 10, 2008

Study Start

June 2008

Date type not reported

This date has not been verified as actual or estimated.

NCT00784121

Dermacyd Breeze (Lactic Acid) Pocket BR - Compatibility

Phase 3Completed

NCT00783939

Dermacyd PH_DETINBACK Tangerine Mix (Lactic Acid) - Safety.

Phase 3Completed

NCT00497783

Acceptability Lactoserum (Dermacyd Delicata - New Fragrance)

Phase 4Completed

NCT00881270

Dermacyd Infantile - Acceptability.

Phase 4Completed

NCT00497692

Topic Compatibility Lactoserum (Dermacyd Delicata - New Fragrance)

Phase 4Completed

NCT00881348

Dermacyd Infantile (Lactic Acid) - Photo Evaluation.

Phase 4Completed

Pregnancy or breastfeeding women

Use of anti-inflammatory or immune-suppression drugs

Topical medication use at the tested region

Active cutaneous gynaecological disease which may interfere in study results

Personal history of allergic disease at the area to be treated

Allergic or atopic history

The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

Contact the study team to confirm eligibility.

Primary Completion

August 2008

Actual (reported)

Study Completion

August 2008

Actual (reported)

Last Updated

July 20, 2009

Record last verified: 2009-07

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT00712868
Data provider: ClinicalTrials.gov
Source updated: 2009-07-20
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:22:59 UTC

Locations

MX(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Study Arms (1)

1

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Interventions

Intervention Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

Source record

Locations